| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Rivervest Venture Fund Iv, L.P. is a 10% Owner at Xilio Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $7.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 2021 | XLO Xilio Therapeutics, Inc. | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +21.0% | -12.5% | -86.4% |